Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

CPX-351+GO in Subjects 55 Years Old, or Older, With AML

Phase 1

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Drug: CPX-351
Drug: Gemtuzumab Ozogamicin

First Posted Date: 2019-03-18

Last Posted Date: 2023-03-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 11

Registration Number: NCT03878927

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Phase 2

Active, not recruiting

Conditions: Mantle Cell Lymphoma

Interventions: Drug: Acalabrutinib
Drug: Lenalidomide
Drug: Rituximab
Drug: Obinutuzumab

First Posted Date: 2019-03-05

Last Posted Date: 2025-06-06

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 37

Registration Number: NCT03863184

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Other: Control
Other: Case Management Intervention

First Posted Date: 2019-03-01

Last Posted Date: 2025-04-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 500

Registration Number: NCT03858998

Locations: 🇹🇿
Busisi Health Center, Busisi, Mwanza, Tanzania
🇹🇿
Magu District Hospital, Magu, Mwanza, Tanzania
🇹🇿
Nyamilama Health Center, Nyamilama, Mwanza, Tanzania

and more 13 locations

Developing a Pain Identification and Communication Toolkit

Not Applicable

Terminated

Conditions: Dementia
Chronic Pain

Interventions: Behavioral: Information Pamphlet
Behavioral: PICT Workbook

First Posted Date: 2019-02-25

Last Posted Date: 2022-06-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 85

Registration Number: NCT03853291

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Early Phase 1

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Drug: Abemaciclib

First Posted Date: 2019-02-12

Last Posted Date: 2024-12-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT03837821

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

and more 1 locations

Patient-caregiver Communication Intervention for Prognostic Understanding

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: Talking about Cancer (TAC)

First Posted Date: 2019-02-07

Last Posted Date: 2023-01-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 28

Registration Number: NCT03833817

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Fetal Genome Profiling Via Trophoblast Cells

Not Applicable

Terminated

Conditions: Fetal Growth Retardation

Interventions: Diagnostic Test: Fetal Genome Profiling.

First Posted Date: 2019-02-06

Last Posted Date: 2023-08-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT03832634

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Converting HR+ Breast Cancer Into an Individualized Vaccine

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: Focal Radiation therapy
Biological: CDX-301
Drug: Pembrolizumab (200mg IV for 30 minutes

First Posted Date: 2019-01-15

Last Posted Date: 2025-02-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 100

Registration Number: NCT03804944

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York, United States
🇺🇸
Weill Cornell Medicine New York Presbyterian Hospital, New York, New York, United States

and more 5 locations

Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine

Phase 4

Completed

Conditions: Male Infertility

Interventions: Drug: Standard Bupivacaine
Drug: Liposomal Bupivacaine

First Posted Date: 2019-01-14

Last Posted Date: 2020-12-17

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT03802864

Locations: 🇺🇸
Weill Cornell Medicine Department of Urology, New York, New York, United States

A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

Not Applicable

Recruiting

Conditions: PTSD

Interventions: Behavioral: Interpersonal Psychotherapy
Behavioral: Exposure Therapy

First Posted Date: 2019-01-14

Last Posted Date: 2025-03-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 208

Registration Number: NCT03803332

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy